Generic Drug Producers Have $45 Billion OpportunityRupert Hargreaves
Generic drug producers have been handed windfall sales over the past decade. According to a new report from Morgan Stanley on the state of the generic drug industry published this week, $160 billion to $170 billion of branded sales have lost patent protection over the last ten years, and generic producers have been quick to take advantage.
- HHS Secretary Calls for Price Controls on Some Prescription Drugs
- War . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.